IGF-1 LR3 1 mg

IGF-1 LR3 1 mg (Long R3 Insulin-Like Growth Factor-1)

IGF-1 LR3, or Long R3 Insulin-Like Growth Factor-1, is a modified analogue of naturally occurring IGF-1. It is studied in laboratory and cell-culture research involving growth-factor signalling and cellular development.

Its modified amino-acid sequence reduces binding to IGF-binding proteins when compared with native IGF-1. This characteristic allows researchers to examine more sustained IGF-1 receptor activity within controlled experimental models.

Research involving IGF-1 LR3 explores receptor activation and the downstream pathways associated with cellular growth, protein synthesis, glucose metabolism, and nutrient signalling. It is also relevant to studies involving muscle-cell biology, tissue development, cellular regeneration, and metabolic regulation.

Researchers value IGF-1 LR3 because it provides a specialized tool for examining the IGF-1 receptor and related intracellular pathways. Its distinct structure also supports comparisons with naturally occurring IGF-1 and other growth-factor research models.

For related endocrine research, explore HGH 191AA and Tesamorelin. These compounds interact with the broader growth hormone and IGF-1 axis through different mechanisms.

For laboratories seeking IGF-1 LR3 in Canada, it offers a well established model for growth factor, metabolic, and cellular signalling research.

Product Specifications

• Form: Lyophilized powder
• Scientific / alternate name: Long R3 IGF-1
• Vial size: 1 mg

For laboratory and research purposes only. Not intended for human or veterinary use, diagnosis, treatment, or consumption.